Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-09 · accession 0001493152-22-016372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-10 | 2022-06-09 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $10.90 | +4,500 | 1.24M | +0.4% | +$49.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-09 | P | A | 4,500 | $10.90 | 1,243,453 | D | — | — |